Hoya Group's corporate venturing unit has led a series A round for fluid-optic intraocular lens developer LensGen which could be increased to $26m.
US-based intraocular lens developer LensGen has completed a $21m series A round led by Hoya Ventures, the corporate venture capital vehicle for healthcare and IT technology provider Hoya Group.
Relativity Healthcare Partners also contributed to the round, which includes a provision for the participants to add another $5m in funding.
LensGen is developing what it claims will be the first ever modular, fluid-optic accommodating intraocular lens, in order to restore clear vision for patients suffering from cataracts and presbyopia.
Augustine…
